{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:08:18Z","timestamp":1779091698278,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.advms.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:28:45Z","timestamp":1770683325000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can liver-associated parameters serve as prognostic factors in pancreatic cancer? \u2013 A retrospective analysis of a large-capacity centre"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8665-2875","authenticated-orcid":false,"given":"Marta","family":"Fudalej","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Badowska-Kozakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Depta\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.advms.2026.02.001_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.advms.2026.02.001_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1039\/D3MO00250K","article-title":"Pancreatic cancer environment: from patient-derived models to single-cell omics","volume":"20","author":"Gu","year":"2024","journal-title":"Mol Omics"},{"key":"10.1016\/j.advms.2026.02.001_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"Cancer Lett"},{"issue":"7","key":"10.1016\/j.advms.2026.02.001_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.advms.2026.02.001_bib6","series-title":"Sleisenger and Fordtran's gastrointestinal and liver disease E-book: pathophysiology, diagnosis, management","author":"Feldman","year":"2020"},{"issue":"11","key":"10.1016\/j.advms.2026.02.001_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.advms.2026.02.001_bib8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2022.3829","article-title":"Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial","volume":"8","author":"Conroy","year":"2022","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.advms.2026.02.001_bib9","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1245\/s10434-020-09149-3","article-title":"Total neoadjuvant therapy for operable pancreatic cancer","volume":"28","author":"Kim","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.advms.2026.02.001_bib10","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1125","key":"10.1016\/j.advms.2026.02.001_bib11","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210044","article-title":"The role of radiotherapy in locally advanced pancreatic cancer","volume":"94","author":"Huguet","year":"2021","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","article-title":"Current and future immunotherapeutic approaches in pancreatic cancer treatment","volume":"17","author":"Farhangnia","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20230025","article-title":"Anti-angiogenic therapy enhances cancer immunotherapy: mechanism and clinical application","volume":"2","author":"Li","year":"2024","journal-title":"Interdiscipl Med"},{"issue":"6","key":"10.1016\/j.advms.2026.02.001_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.5858\/2008-132-931-MPOCRF","article-title":"Metastatic patterns of cancers: results from a large autopsy study","volume":"132","author":"Disibio","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.advms.2026.02.001_bib15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pan.2024.06.004","article-title":"The impact of metastatic sites on survival rates and predictors of extended survival in patients with metastatic pancreatic cancer","volume":"24","author":"Levine","year":"2024","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.advms.2026.02.001_bib16","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.7150\/jca.50317","article-title":"Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data","volume":"12","author":"Wu","year":"2021","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.advms.2026.02.001_bib17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pan.2021.01.014","article-title":"The impact of different metastatic patterns on survival in patients with pancreatic cancer","volume":"21","author":"He","year":"2021","journal-title":"Pancreatology"},{"issue":"10","key":"10.1016\/j.advms.2026.02.001_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12101657","article-title":"Liver function-how to screen and to diagnose: insights from personal experiences, controlled clinical studies and future perspectives","volume":"12","author":"Buechter","year":"2022","journal-title":"J Personalized Med"},{"issue":"2","key":"10.1016\/j.advms.2026.02.001_bib19","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.advms.2026.02.001_bib20","series-title":"Alanine Aminotransferase (ALT) Test. StatPearls. Treasure Island (FL): Statpearls publishing copyright \u00a9 2025","author":"Moriles","year":"2025"},{"key":"10.1016\/j.advms.2026.02.001_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.procbio.2019.10.034","article-title":"A comprehensive review of bilirubin determination methods with special emphasis on biosensors","volume":"89","author":"Rawal","year":"2020","journal-title":"Process Biochem"},{"key":"10.1016\/j.advms.2026.02.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101125","article-title":"Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance","volume":"77","author":"Dong","year":"2024","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.advms.2026.02.001_bib23","first-page":"207","article-title":"Chemioterapia w leczeniu chorych z przerzutami do w\u0105troby (Chemotherapy in the treatment of patients with liver metastases)","volume":"1","author":"Depta\u0142a","year":"2020"},{"issue":"6","key":"10.1016\/j.advms.2026.02.001_bib24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/15384101.2020.1728013","article-title":"Inflammatory networks cultivate cancer cell metastasis to the liver","volume":"19","author":"Lee","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.advms.2026.02.001_bib25","article-title":"Predictive value of serum albumin levels on cancer survival: a prospective cohort study","volume":"14","author":"Tang","year":"2024","journal-title":"Front Oncol"},{"issue":"15","key":"10.1016\/j.advms.2026.02.001_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153731","article-title":"The hepatic pre-metastatic niche","volume":"14","author":"Ormseth","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"24","key":"10.1016\/j.advms.2026.02.001_bib27","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1158\/1078-0432.CCR-16-0460","article-title":"Role of the microenvironment in liver metastasis: from Pre- to prometastatic niches","volume":"22","author":"Brodt","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5603\/ocp.98619","article-title":"The prevalence and impact of overweight and hypertension among patients with pancreatic cancer","volume":"21","author":"Fudalej","year":"2025","journal-title":"Oncol Clin Pract"},{"issue":"12","key":"10.1016\/j.advms.2026.02.001_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122840","article-title":"Diabetes mellitus and pancreatic ductal adenocarcinoma-prevalence, clinicopathological variables, and clinical outcomes","volume":"14","author":"Badowska-Kozakiewicz","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib30","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1038\/s41598-025-93184-1","article-title":"Association between De-Ritis ratio (AST\/ALT) and mortality in patients with chronic kidney disease: a retrospective cohort study","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2026.02.001_bib31","article-title":"De Ritis ratio and cardiovascular disease: evidence and underlying mechanisms","volume":"8","author":"Ndrepepa","year":"2023","journal-title":"J Lab Prec Med"},{"key":"10.1016\/j.advms.2026.02.001_bib32","article-title":"Aspartate aminotransferase and cardiovascular disease\u2014a narrative review","volume":"6","author":"Ndrepepa","year":"2020","journal-title":"J Lab Prec Med"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.juro.2015.01.083","article-title":"The preoperative AST\/ALT (De ritis) ratio represents a poor prognostic factor in a cohort of patients with nonmetastatic renal cell carcinoma","volume":"194","author":"Bezan","year":"2015","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.advms.2026.02.001_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24356","article-title":"Elevated AST\/ALT ratio is associated with all-cause mortality and cancer incident","volume":"36","author":"Chen","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.54614\/eurjther.2022.0038","article-title":"Effectiveness of De Ritis (AST\/ALT) Ratio in Predicting Biochemical Recurrence in Patients Underwent Radical Prostatectomy for Localized Prostate Cancer","volume":"28","author":"Ta\u015ftemur","year":"2023","journal-title":"Eur J Therapeutics"},{"issue":"4","key":"10.1016\/j.advms.2026.02.001_bib36","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/MS9.0000000000000311","article-title":"Clinicopathological correlation of aspartate aminotransferase-to-platelet ratio (APRI) and aspartate aminotransferase-to-alanine aminotransferase ratio (AAR) with survival in esophageal carcinoma patients: a retrospective cohort analysis of 951 patients","volume":"85","author":"Zafar","year":"2023","journal-title":"Ann Med Surg"},{"issue":"3","key":"10.1016\/j.advms.2026.02.001_bib37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.29271\/jcpsp.2021.03.282","article-title":"An evaluation of the effect of preoperative inflammation-based factors on survival in gastric cancer patients","volume":"31","author":"Durhan","year":"2021","journal-title":"J Coll Physician Surg Pak"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12885-017-3523-y","article-title":"Prognostic value of pretreatment serum alanine aminotransferase\/aspartate aminotransferase (ALT\/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma","volume":"17","author":"Huang","year":"2017","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.advms.2026.02.001_bib39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s11255-017-1618-7","article-title":"The significance of De Ritis (aspartate transaminase\/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients","volume":"49","author":"Wang","year":"2017","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1016\/j.advms.2026.02.001_bib40","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/j.clgc.2016.08.023","article-title":"De Ritis Ratio (AST\/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery","volume":"15","author":"Lee","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.advms.2026.02.001_bib41","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3389\/fonc.2020.01650","article-title":"Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase\/Alanine Transaminase Ratio) in Urological Cancers: a Systematic Review and Meta-Analysis","volume":"10","author":"Su","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.advms.2026.02.001_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919900872","article-title":"The AST\/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study","volume":"12","author":"Riedl","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"18","key":"10.1016\/j.advms.2026.02.001_bib43","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.3390\/jcm12186017","article-title":"Serum albumin levels: a biomarker to be repurposed in different disease settings in clinical practice","volume":"12","author":"Gremese","year":"2023","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.advms.2026.02.001_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071986","article-title":"Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer","volume":"12","author":"Almasaudi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.advms.2026.02.001_bib45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4240\/wjgs.v7.i12.370","article-title":"Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate?","volume":"7","author":"Nazha","year":"2015","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1758-5996-3-11","article-title":"Albumin binding ligands and albumin conjugate uptake by cancer cells","volume":"3","author":"Frei","year":"2011","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"10.1016\/j.advms.2026.02.001_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/nu9030183","article-title":"Pancreatic exocrine insufficiency in pancreatic cancer","volume":"9","author":"Vujasinovic","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.advms.2026.02.001_bib48","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fnut.2021.734735","article-title":"Hypoalbuminaemia as a prognostic biomarker of first-line treatment resistance in metastatic non-small cell lung cancer","volume":"8","author":"Stares","year":"2021","journal-title":"Front Nutr"},{"issue":"16_suppl","key":"10.1016\/j.advms.2026.02.001_bib49","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.e18027","article-title":"Hypoalbuminemia, body mass index, and weight loss as predictors of outcomes in head and neck cancer","volume":"41","author":"Kennedy","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.advms.2026.02.001_bib50","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00404-019-05278-7","article-title":"Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery","volume":"300","author":"Bekos","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.advms.2026.02.001_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1039121","article-title":"The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"9","author":"Guven","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.advms.2026.02.001_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr J"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12885-020-07023-9","article-title":"Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"issue":"16","key":"10.1016\/j.advms.2026.02.001_bib54","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.7150\/jca.20917","article-title":"Alkaline phosphatase-to-albumin ratio as a prognostic indicator in pancreatic ductal adenocarcinoma after curative resection","volume":"8","author":"Pu","year":"2017","journal-title":"J Cancer"},{"issue":"4","key":"10.1016\/j.advms.2026.02.001_bib55","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.21037\/jgo-21-430","article-title":"Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients","volume":"12","author":"Wang","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib56","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/s41598-023-28889-2","article-title":"Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.advms.2026.02.001_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1186\/s12885-019-6004-7","article-title":"Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer","volume":"19","author":"Xiao","year":"2019","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.advms.2026.02.001_bib58","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2217\/fon-2023-0137","article-title":"Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer","volume":"19","author":"Catalano","year":"2023","journal-title":"Future Oncol"},{"issue":"8","key":"10.1016\/j.advms.2026.02.001_bib59","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1007\/s00464-021-08981-2","article-title":"Comparison of outcomes between secondary fully covered and uncovered self-expandable metal stents in the treatment of recurrent biliary obstruction of pancreatic cancer","volume":"36","author":"Kataoka","year":"2022","journal-title":"Surg Endosc"},{"issue":"5","key":"10.1016\/j.advms.2026.02.001_bib60","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/107327480000700508","article-title":"Endoscopic palliation for inoperable pancreatic cancer","volume":"7","author":"Das","year":"2000","journal-title":"Cancer Control"},{"issue":"4","key":"10.1016\/j.advms.2026.02.001_bib61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijsu.2013.02.023","article-title":"Comparison of prognosis between patients of pancreatic head cancer with and without obstructive jaundice at diagnosis","volume":"11","author":"Nakata","year":"2013","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.advms.2026.02.001_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/hpb.12094","article-title":"Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas","volume":"16","author":"Strasberg","year":"2014","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.advms.2026.02.001_bib63","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1002\/cam4.1848","article-title":"Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.advms.2026.02.001_bib64","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1159\/000441310","article-title":"Patients with advanced pancreatic cancer and hyperbilirubinaemia: review and German expert opinion on treatment with nab-Paclitaxel plus gemcitabine","volume":"38","author":"Vogel","year":"2015","journal-title":"Oncol Res Treat"},{"issue":"2","key":"10.1016\/j.advms.2026.02.001_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22272","article-title":"The prognostic impact of serum bilirubin in stage IV colorectal cancer patients","volume":"32","author":"Yang","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.advms.2026.02.001_bib66","doi-asserted-by":"crossref","first-page":"10157","DOI":"10.2147\/CMAR.S230620","article-title":"Preoperative bilirubin level predicts overall survival and tumor recurrence after resection for perihilar cholangiocarcinoma patients","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.advms.2026.02.001_bib67","first-page":"2025","article-title":"Applications and challenges of biomarker-based predictive models in proactive health management","volume":"13","author":"Zhao","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.advms.2026.02.001_bib68","series-title":"StatPearls. Treasure Island (FL): Statpearls publishing copyright \u00a9 2025","article-title":"Type I and type II errors and statistical power","author":"Shreffler","year":"2025"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112626000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112626000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:39:03Z","timestamp":1779089943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112626000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1896112626000040"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2026.02.001","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can liver-associated parameters serve as prognostic factors in pancreatic cancer? \u2013 A retrospective analysis of a large-capacity centre","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Medical University of Bialystok. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}